| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |